|
Volumn 24, Issue 7, 2014, Pages 370-373
|
The influence of dopamine β-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: A preliminary study
|
Author keywords
cocaine dependence; dopamine hydroxylase; levodopa; polymorphism; treatment
|
Indexed keywords
BENZOYLECGONINE;
CARBIDOPA PLUS LEVODOPA;
COCAINE;
DOPAMINE;
DOPAMINE BETA MONOOXYGENASE;
PLACEBO;
RIBOFLAVIN;
ADULT;
ARTICLE;
COCAINE DEPENDENCE;
COGNITIVE THERAPY;
CONTROLLED STUDY;
DNA POLYMORPHISM;
DOUBLE BLIND PROCEDURE;
DRUG DOSE TITRATION;
ENZYME ACTIVITY;
FEMALE;
GENETIC SCREENING;
GENOTYPE;
HUMAN;
MAINTENANCE DRUG DOSE;
MAJOR CLINICAL STUDY;
MALE;
MEDICATION COMPLIANCE;
OUTCOME ASSESSMENT;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT RESPONSE;
URINE LEVEL;
ADULT;
CARBIDOPA;
COCAINE-RELATED DISORDERS;
DOPAMINE BETA-HYDROXYLASE;
DOUBLE-BLIND METHOD;
FEMALE;
GENOTYPE;
HUMANS;
LEVODOPA;
MALE;
MIDDLE AGED;
ODDS RATIO;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
TREATMENT OUTCOME;
|
EID: 84902266861
PISSN: 17446872
EISSN: 17446880
Source Type: Journal
DOI: 10.1097/FPC.0000000000000055 Document Type: Article |
Times cited : (15)
|
References (10)
|